Airways and Vascular Remodelling in Asthma and Cardiovascular Disease

Professor Clive P. Page, BSc PhD OBE HonFBPhS is a Professor of Pharmacology, King’s College London and Director of the Sackler Institute of Pulmonary Pharmacology, King’s College London. Clive’s main research interests are in the pharmacology of inflammation and respiratory disease and he has published over 250 scientific papers. Clive was the co-founder and previous Chairman of the Board of Verona Pharma plc, an AIM listed Company developing new drugs for the treatment of Respiratory Diseases. He is a Non Executive Director of and on boards of several companies. He was awarded the Society of Biology President’s Medal in 2012 for an outstanding contribution to the life sciences over the previous year. He is a Fellow of the Royal Society of Biology and an Honorary Fellow and President Elect of the British Pharmacological Society. In 2017, Clive was awarded an OBE for Services to Pharmacology.

P.K. Jefferey, Structural Changes in Asthma.
T. Cocks, Changes in Vascular Reactivity in Artherogenesis: Markers of Endothial Cell Dysfunction Associated with Initiation of the Disease.
J.H. Campbell and G.R. Campbell, Vascular Smooth Muscle in Culture and its Relevance to the Study of Arthrogenesis.
V. Lindner, In Vivo Investigations of Vascular Smooth Muscle Remodelling.
M.J. Karnovsky and E.R. Edelman, Heparin/Heparan Sulphate Regulation of Vascular Smooth Muscle Cell Behaviour.
M.I. Kotlikoff, Regulation of Cytoplasmic Calcium in Airway Smooth Muscle Cells: Implications for Growth and Contractility.
J.G. Martin, Animal Studies with Drugs Affecting Airway Smooth Muscle Thickening.
M. Okazawa, P.D. Pare, J.C. Hogg, and R.K. Lambert, Mechanical Consequences of Remodelling of the Airway Wall.
A.J. Woolcock and J.K. Peat, Is Asthma a Reversible Disease?
L.A. Laitinen and A. Laitinen, Anti-Inflammatory Therapy of Asthma: Corticosteroids.
P. Konig, Anti-Inflammatory Therapy of Asthma: Non-Steroid Disease Modifying Agents.
P. Gresele, Design of Large Multicentre Therapeutic Trials.
The Relevance of the Cardiovascular Experience to the Design of Long Term Anti-Asthma Trials.
Discussion Section.
Subject Index.